Back

Rate vs. rhythm control in patients with transthyretin amyloid cardiomyopathy and atrial fibrillation

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Treatment of atrial fibrillation: there is more than ablation Antiarrhythmic Drug Treatment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Paul Lustig

Medical University of Vienna, Vienna (Austria)

5 More presentations in this session

Presentation thumbnail
Frequency of recurrence following cardioversion of an initial atrial fibrillation episode
Doctor K. Usuda (Cambridge, US)
Abstract Slides Video
Presentation thumbnail
Joint relevance of CYP2D6 and H558R in the efficacy and toxicity of flecainide in patients with atrial fibrillation: a cohort study.
Mr M. Trincado Ave (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of catheter ablation versus antiarrhythmic drug therapy in ventricular tachycardia management: a systematic review and meta-analysis
Doctor L. Lucena (Florianopolis, BR)
Abstract Slides Video
Presentation thumbnail
Safety outcomes of catheter ablation versus antiarrhythmic drugs in atrial fibrillation: a comprehensive systematic review and meta-analysis
Doctor M. SHAWKI (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Prevention of atrial fibrillation recurrence with vitamin C during catheter ablation
Doctor A. Tian (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Treatment of atrial fibrillation: there is more than ablation
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Impact of rhythm control in wild-type transthyretin cardiac amyloidosis and atrial fibrillation: a retrospective analysis
thumbnail
Congress Session
Treatment of atrial fibrillation: there is more than ablation
thumbnail
Congress Presentation
Rate or rhythm control?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources